Stop Believing These 3 Common Myths About Prostate Cancer
Common myths about prostate cancer, including misconceptions about prostate-specific-antigen (PSA) testing and prostate surgery.
By: Eric Klein, MD
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
When it comes to prostate cancer screening and treatment, misconceptions persist.
It’s important to separate myths from facts:
Although PSA screening is mostly performed in men over 65, the men who really benefit from the test are young and have a PSA pattern that highly suggests cancer. If these young men take their test results seriously, they are biopsied for high-grade cancer and then treated and cured of their cancer.
Other conditions, including non-cancerous prostate enlargement, can cause higher PSA, so a biopsy is the only way to know for sure.
In experienced hands and the early stages of prostate cancer, long-term issues with urinary leakage are minimal. In the majority of men with early stage prostate cancer, it’s possible to do nerve-sparing surgery and have normal erections.
Remember that prostate cancer can often be detected early through screening. A digital rectal exam is one screening method, and a PSA is another.
According to the American Cancer Society, other than skin cancer, prostate cancer is the most common cancer in American men.